Replies to post #3965 on EOM Pharmaceutical Holdings Inc. (IMUC)

[Thor Von Thorson]

And then some!!!

ImmunoCellular Therapeutics, Ltd. (NYSE:IMUC) has accumulated 75.71% over the course of one week. It seems that ImmunoCellular Therapeutics, Ltd. (NYSE:IMUC) might see weakness given an ABR of 4 or Sell rating. Analysts, on average, seem bullish as they suggest IMUC is worth $4.63 more, giving a target price of $5 a share.

Source:
https://allstocknews.com/2017/08/23/critical-levels-to-breach-walter-investment-management-corp-wac-immunocellular-therapeutics-ltd-imuc/